{"certainAgreement":{"otherDetails":"* Multicenter publication must include input from investigators and Celgene, and has priority over subset (single center) publication, for 1 year after study completion.\n* Investigators have publication right after multicenter publication is complete (or 1 year after study completion), whichever is first. Celgene has 45 days to review and comment on draft manuscript/presentation, and may ask for an additional delay (not to exceed 90 days total) to address intellectual property issues.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"clinicaltrialdisclosure@celgene.com","organization":"Celgene Corporation","phone":"1-888-260-1599","title":"Associate Director, Clinical Trials Disclosure"}}